• Far broader and more inclusive of TBRF Borreliae (including, but not limited to, B. miyamotoi) species than standard serologies.
• Detects antibodies to TBRF Borrelia species from North American, European and Australian strains.
• Provides a simple, cost-effective, yes/no result with no complicated interpretation necessary
Test
Broad Coverage TBRF Borrelia Ab Assay
$195.00
The TBRF Broad Coverage Antibody Assay (BCA) is a qualitative test designed to detect IgM and IgG antibodies to TBRF Borreliae group-specific antigens in human serum. A positive test suggests exposure to the TBRF Borreliae group, and should be used in conjunction with patient clinical symptoms and history. The BCA Assay is a simple and cost-effective test, which gives either a positive or negative result.
Principle
Detects IgM and IgG antobodies to the TBRF Borreliae group, and a positive test suggests exposure to the TBRF Borreliae group, and should be used in conjunction with patient clinical symptoms and history. For specific protein or band information, an ImmunoBlot IgM or IgG test should be ordered to provide more information and possible speciation of the Borrelia. The sensitivity of the TBRF Borrelia BCA Assay is greater than 90%, and the specificity is greater than 94%.
Tube / Specimen Requirements
1 SST/ minimum volume 0.5mL serum
CPT Code(s)
0044U
Sample Report
View
Positive: TBRF Borreliae group-specific antigens detected.
Negative: TBRF Borreliae group-specific antigens not detected
A positive result suggests exposure to TBRF Borrelia. For diagnostic purposes, immunoblot test results should be used in conjunction with clinical symptoms and other evidence available to the diagnosing physician. If the test result is indeterminate, testing with another method or retesting in 6-8 weeks is recommended.
Related Tests
GET STARTED TODAY!
The first step in getting tested with IGeneX is to order a collection kit. Choose between a Blood, Urine, or Miscellaneous kit.
WHY IGENEX FOR TICK-BORNE DISEASE TESTING?
- CLIA certified in all 50 states
- Long track record of success since 1991
- Offers testing that is nearly twice as accurate as CDC recommended tests
- Tests for all major tick-borne illnesses, including Lyme disease, TBRF, Babesia, Bartonella, and Rickettsia
- Utilizes comprehensive testing methods such as PCR, ImmunoBlots, IgXSpot and FISH
- Has become a nationwide leader in COVID-19 testing due to a relentless focus on customer satisfaction
